Sepio Capital, LP Vertex Pharmaceuticals Inc Transaction History

Sepio Capital, LP

$1.03 Billion
Q3 2024

A detailed history of Sepio Capital, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sepio Capital, LP holds 7,031 shares of VRTX stock, worth $2.97 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

7,031

Previous 7,095 0.9%

Holding current value

$2.97 Million

Previous $3.33 Million 1.68%

% of portfolio

0.32%

Previous 0.36%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $29,440 - $32,369	-64 Reduced 0.9%	7,031 $3.27 Million
Q2 2024 Aug 15, 2024	SELL	$392.81 - $485.53 $17,676 - $21,848	-45 Reduced 0.63%	7,095 $3.33 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $68,491 - $74,941	-168 Reduced 2.3%	7,140 $2.98 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $508,669 - $609,038	-1,483 Reduced 16.87%	7,308 $2.97 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $37,876 - $40,595	112 Added 1.29%	8,791 $3.06 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $133,628 - $149,561	-425 Reduced 4.67%	8,679 $3.05 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $582,604 - $664,616	-2,057 Reduced 18.43%	9,104 $2.87 Million
Q4 2022 Feb 03, 2023	SELL	$285.76 - $321.48 $671,250 - $755,156	-2,349 Reduced 17.39%	11,161 $3.22 Million
Q3 2022 Oct 28, 2022	SELL	$273.83 - $305.53 $287,521 - $320,806	-1,050 Reduced 7.21%	13,510 $3.91 Million
Q2 2022 Jul 26, 2022	SELL	$234.96 - $292.55 $1.18 Million - $1.46 Million	-5,007 Reduced 25.59%	14,560 $4.1 Million
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $353,164 - $416,247	-1,595 Reduced 7.54%	19,567 $5.11 Million
Q4 2021 Jan 25, 2022	BUY	$177.01 - $223.45 $58,944 - $74,408	333 Added 1.6%	21,162 $4.65 Million
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $3.78 Million - $4.23 Million	20,829 New	20,829 $3.78 Million

Others Institutions Holding VRTX

# of Institutions

1,718

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $108B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Account